B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Introduction: B lymphocytes might play a pathogenic role in dermal fibrosis in systemic sclerosis (SSc). B-cell activating factor (BAFF), a key cytokine for B-cell activation, is increased in the serum and the skin of patients with SSc. However, the ability of B cells directly to stimulate dermal fibroblasts and the role of BAFF are not fully understood. We therefore investigated the involvement of B cells and BAFF in the expression of collagen and profibrotic markers by dermal fibroblasts. Methods: Cocultures of blood B cells from healthy blood donors and normal or SSc dermal fibroblasts stimulated with anti-IgM and BAFF were performed. Alpha-SMA, TIMP1, MMP9, COL1A1, COL1A2, and COL3A1 mRNA expression were determined by quantitative RT-PCR. Soluble collagen, BAFF, IL-6, IL-1β, TGF-β1, and CCL2 protein secretion were assessed. Results: Coculture of blood B cells and dermal fibroblasts isolated from SSc patients induced IL-6, TGF-β1, CCL2, and collagen secretion, as well as Alpha-SMA, TIMP1, and MMP9 expression in dermal fibroblasts. Transwell assays demonstrated that this induction was dependent on cell-cell contact. Addition of anti-IgM and BAFF to the coculture increased IL-6, CCL2, TGF-β1, and collagen secretion. B cell- and BAFF-induced collagen secretion was highly reduced by anti-TGF-β1 antibodies. Conclusions: Our results showed for the first time a direct role of B cells on the production of collagen by dermal fibroblasts, which is further enhanced by BAFF. Thus, these results demonstrate a new pathogenic role of B cells and BAFF in fibrosis and systemic sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this effect cell-cell contact was required, as the use of a transwell system negated the stimulatory effect of B cells on fibroblast activity (175).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [175]
In the citing paper
“Finally, B lymphocytes have also been demonstrated to be able to promote fibrosis; co-culture of B cells with skin fibroblasts induced the expression of collagen and αSMA by the latter (175).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [175]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Ng, L. G., Sutherland, A. P. R., Newton, R., Qian, F., Cachero, T. G., Scott, M. L., Thompson, J. S., Wheway, J., Chtanova, T., Groom, J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.807 · Cited by 500
Systemic and cell type-specific gene expression patterns in scleroderma skin
Whitfield, M. L., Finlay, D. R., Murray, J. I., Troyanskaya, O. G., Chi, J.-T., Pergamenschikov, A., McCalmont, T. H., Brown, P. O., Botstein, D., & Connolly, M. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635114100 · Cited by 409
Duncan, M. R., & Berman, B. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483971 · Cited by 323
Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity
Sato, S., Hasegawa, M., Fujimoto, M., Tedder, T. F., & Takehara, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6635 · Cited by 320
Sato, S., Fujimoto, M., Hasegawa, M., & Takehara, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20274 · Cited by 317
Mart�nez-Lav�n, M., Hermosillo, A. G., Rosas, M., & Soto, M.-E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1966::aid-art11>3.0.co;2-o · Cited by 306
Research works printed but not linked: 1
- Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM: Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Arthritis Rheum. 1998, 41: 2039-2047. 10.1002/1529-0131(199811)41:11<2039::AID-ART20>3.0.CO;2-1. · DOI · Paper page
Cited by
Items 101–155 of 155
Prenc, E., Pulanić, D., Pučić‐Baković, M., Pezer, M., Desnica, L., Vrḫovac, R., Nemet, D., & Pavletic, S. Z. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.02.015 · Cited by 11
Maître, M. L., Guerrier, T., Collet, A., Derhourhi, M., Meneboo, J., Toussaint, B., Bonnefond, A., Villenet, C., Sebda, S., Bongiovanni, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1373464 · Cited by 12
Simple gene signature to assess murine fibroblast polarization
Ledoult, E., Jendoubi, M., Collet, A., Guerrier, T., Largy, A., Speca, S., Vivier, S., Bray, F., Figeac, M., HACHULLA, E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15640-6 · Cited by 10
Boin, F., & Chizzolini, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_13 · Cited by 10
Wu, Q., Liu, Y., Xie, Y., Wei, S., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622021 · Cited by 10
Alterations in peripheral T‐ and B‐cell subsets in patients with systemic sclerosis
Wu, J., Zhang, X., Shen, L., Wei, Q., Lin, Z., Jin, O., & Gu, J. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15145 · Cited by 10
Myofibroblasts, B Cells, and Mast Cells in Different Types of Long-Standing Acne Scars
Chancheewa, B., Asawanonda, P., Noppakun, N., & Kumtornrut, C. (2022) · Skin Appendage Disorders · doi:10.1159/000524566 · Cited by 9
Bell, S. R. C., Young, J. A., List, E. O., Basu, R., Geitgey, D. K., Lach, G., Lee, K. Y., Swegan, D., Caggiano, L. J., Okada, S., et al. (2023) · Endocrinology · doi:10.1210/endocr/bqad038 · Cited by 8
Andreev, G., Vollmer, T., Zirngibl, M., Werner, M., Grabbert, M. T., Schilling, O., Rogg, M., & Schell, C. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104130 · Cited by 8
Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis
Zhang, Y., Yang, Y., Gao, X., Gao, W., & Zhang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1263839 · Cited by 8
Fibroblasts as Immunological Sentinels in Cutaneous Inflammation: A Review
Quan, T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020556 · Cited by 7
HLA-G Is Widely Expressed by Mast Cells in Regions of Organ Fibrosis in the Liver, Lung and Kidney
Mouchet, N., Vu, N., Turlin, B., Rioux-Leclercq, N. C., Jouneau, S., Samson, M., & Amiot, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212490 · Cited by 7
Cellular and Molecular Diversity in Scleroderma
Hinchcliff, M., García-Milian, R., Donato, S. D., Dill, K. E., Bundschuh, E., & Galdo, F. D. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2022.101648 · Cited by 7
Maître, M. L., Guerrier, T., Sanges, S., Chepy, A., Collet, A., & Launay, D. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103782 · Cited by 7
González‐Serna, D., Carmona, E. G., Ortego‐Centeno, N., Simeón‐Aznar, C. P., Solans, R., Hernández‐Rodríguez, J., Tolosa, C., Castañeda, S., Narváez, J., Martínez‐Valle, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209343 · Cited by 5
Efficacy of BAFF in Monitoring Treatment Response in Early Vietnamese Systemic Sclerosis Patients
Minh, V. N., Hau, K. T., Takashi, M., Ha, V. N., Bao, L. H., Huyen, M. L., Hữu, D. L., Văn, T. N., Gandolfi, M., Satolli, F., et al. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.070 · Cited by 5
Murphy, S. L., Balzer, N. R., Ranheim, T., Sagen, E. L., Huse, C., Bjerkeli, V., Michelsen, A. E., Finbråten, A., Heggelund, L., Dyrhol‐Riise, A. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379570 · Cited by 4
CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation
Garantziotis, P., Auth, J., Schett, G. A., & Bergmann, C. (2025) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001133 · Cited by 4
The effect of rituximab on encapsulated peritoneal sclerosis in an experimental rat model
Karaköse, S., Bal, Z., Eser, E. P., & Duranay, M. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1911-13 · Cited by 3
Su, K., Roberts, C., Heagerty, A., & Reynolds, J. A. (2023) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/8vvgva · Cited by 3
Effector and regulatory B-cell imbalance in systemic sclerosis: cooperation or competition?
Liu, M. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07086-0 · Cited by 3
Development of Adaptive Immunity and Its Role in Lung Remodeling
Esnault, S. J., & Jarjour, N. N. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-32259-4_14 · Cited by 4
Rezazadeh, M., Jokar, M. H., Aghili, S. M., Mirfeizi, Z., Mahmoudi, M., Morovatdar, N., & Hashemzadeh, K. (2023) · Archives of Rheumatology · doi:10.46497/archrheumatol.2023.9549 · Cited by 3
Baier, E., & Vaglio, A. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2575448 · Cited by 2
Potjewijd, J., Tobal, R., Damoiseaux, J. G. M. C., & van Paassen, P. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2675635 · Cited by 2
Yuan, J., Xu, H., Gan, J.-L., & Zhao, H. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf165 · Cited by 1
Cutaneous Fibrosis and Normal Wound Healing
Hamburg‐Shields, E., Myung, P. S., & Cowper, S. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_32 · Cited by 2
Fabricating a Novel Three-Dimensional Skin Model Using Silica Nonwoven Fabrics (SNF)
Iijima, M., & Iijima, K. (2022) · Applied Sciences · doi:10.3390/app12136537 · Cited by 1
Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis
Trojanowska, M., Varga, J., & Lagares, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_18 · Cited by 2
The Role of B Cells in Systemic Sclerosis
Matsushita, T., & Takehara, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-55708-1_11
Basic Mechanisms Linking Inflammation and Fibrosis
Chizzolini, C. (2017) · Rare diseases of the immune system · doi:10.1007/978-3-319-41349-5_2
de Almeida, I. M. P. A. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/n6x2-xb93 · Cited by 1
Analysis of B lymphocytes in systemic autoimmune vascular diseases
Dumoitier, N. (2017) · theses.fr (ABES) · doi:10.70675/4f922dcez91e3z417az85edzb7bb8aa8c8b2
Les auto-anticorps, marqueurs immunologiques de l’hétérogénéité de la sclérodermie systémique
Sobanski, V. (2017) · theses.fr (ABES) · doi:10.70675/c9473aa4zb66bz4294zb239z7a054ed08bbe
Júnior, J. R. L. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2019.tde-27102021-123822
龚, 玲. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.132322
Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review
Pinyowiwat, P., Rutnin, S., & Chanprapaph, K. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s405553
Inflammation and Immunity in Systemic Sclerosis
Boin, F., Gabrielli, A., & Chizzolini, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_14
Autoantibodies as Markers and Possible Mediators of Scleroderma Pathogenesis
Mecoli, C. A., Maurer, K. D., Rosen, A., & Casciola-Rosen, L. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_15
Transcriptome Analysis of BAFF/BAFF-R System in Murine Nephrotoxic Serum Nephritis
Möckel, T., Boegel, S., & Schwarting, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105415
Role of regulatory T cells in pathogenesis and therapeutics of scleroderma (systemic sclerosis)
Dar, S. A., Das, S., Jawed, A., Nasreen, N., & Rai, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13947-5.00010-5
Lila, A. M., Maslyanskiy, А. L., Dibrov, D. A., Torgashina, A. V., Zotkin, E. G., & MIu, S. (2025) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2025-2-7-17
Follicular helper T cells and fibrotic diseases
Ma, Y., Zhou, Y., & Yu, M. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.105024
Adrenergic signaling induces a pro-tumorigenic B cell state in colorectal cancerPreprint
Thijssen, M. S., Schonkeren, S. L., Coolkens, L., Zou, Y., Temmerman, L., de Vaan, J., Idris, M., Vranken, J., Wouters, K., Vaes, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.23.700260
Relevance physiopathologique des productions cytokiniques dans la Leucémie Lymphoïde Chronique
Mhibik, M. (2018) · theses.fr (ABES) · doi:10.70675/e4aae29eze5ebz4018zb217z9cd5167ee367
Jeljeli, M. M. (2020) · theses.fr (ABES) · doi:10.70675/dfc4dd10z9fb4z4e16z836dz778a7ef9d1c1
Etude des interactions entre les lymphocytes B et la peau dans la sclérodermie systémique
Maître, M. L. (2024) · theses.fr (ABES) · doi:10.70675/4b83f7f1zd61cz4394za897zc4d5039d086f
Altérations des lymphocytes T follicular helper dans la sclérodermie systémique
Beurier, P. (2025) · theses.fr (ABES) · doi:10.70675/a6aed393z5dbez4d78z93ecz3b016cd94056
Telitacicept for refractory IgA nephropathy: a case series
Ma, X. M., Liu, J.-X., Yang, W., Sun, A., Nie, Y.-X., Zheng, J.-N., & Liu, L. (2026) · Journal of Nephrology · doi:10.1093/joneph/aajag012
Long, X., Yuan, S., Luo, Z., Chen, Y., 肖顺娥, 邓呈亮, & Chen, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904807
Speth, J. M., Wong, V. T., Guzman, S. D., Walker, N., Liu, Y., Zemans, R. L., Blackwell, T. S., Aguilar, C. A., Peters-Golden, M. L., & Fortier, S. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-75301-w
Metadata
- Authors
- François, A., Chatelus, E., Wachsmann, D., Sibilia, J., Bahram, S., Alsaleh, G., & Gottenberg, J.-E.
- Affiliations
- Inserm (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Corresponding author
- Gottenberg, Jacques-Eric
- Venue
- Arthritis Research & Therapy
- Published
- 2013-10-28
- Volume
- 15
- Issue
- 5
- Pages
- R168-R168
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC3978899
- OpenAlex
- W2158070434
- Cited by
- 149
- References
- 38
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 12 · 2023: 13 · 2022: 15 · 2021: 14 · 2020: 10 · 2019: 9 · 2018: 12 · 2017: 13 · 2016: 15 · 2015: 10 · 2014: 7 · 2013: 1
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- systemic sclerosis, B cells, B-cell activating factor, dermal fibroblasts, skin fibrosis, collagen synthesis, TGF-β1, interleukin-6, MCP-1, alpha-smooth muscle actin, TIMP-1, MMP-9, cell-cell contact, anti-IgM stimulation
- MeSH terms
- Actins, Antibodies, Anti-Idiotypic, B-Lymphocytes, Cells, Cultured, Collagen, Enzyme-Linked Immunosorbent Assay, Fibroblasts, Fibrosis, Humans, Immunoglobulin M, Muscle, Smooth, Scleroderma, Systemic, Skin, Interleukin-6, Gene Expression, Coculture Techniques, Chemokine CCL2, Tissue Inhibitor of Metalloproteinase-1, Reverse Transcriptase Polymerase Chain Reaction, Matrix Metalloproteinase 9, B-Cell Activating Factor, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.